BCG TOKYO-172 STRAIN VACCINE Uses, Dosage, Side Effects and more
BCG TOKYO-172 STRAIN VACCINE is under investigation in clinical trial NCT03091660 (S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer).
| Attribute | Details |
|---|---|
| Trade Name | BCG TOKYO-172 STRAIN VACCINE |
| Generic | Bacillus calmette-guerin substrain tokyo 172-1 live antigen |
| Bacillus calmette-guerin substrain tokyo 172-1 live antigen Other Names | BCG TOKYO-172 STRAIN VACCINE |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
